Debio 1143 in Combination With Carboplatin and Paclitaxel in Patient With Advanced Solid Malignancies
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Solid Tumors
Interventions: DRUG: Part A: Debio 1143|DRUG: Paclitaxel|DRUG: Carboplatin|DRUG: Part B: Debio 1143
Sponsor: Debiopharm International SA